All News
Top Vaccine Official Resigns From FDA
(MedPage Today) -- The top vaccine official with the FDA has resigned and criticized the nation's top health official for allowing "misinformation and lies" to guide his thinking behind the safety of
Read MoreHow Many HHS Jobs Were Cut This Week?
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
Read MoreSGLT2i Improves Outcomes After TAVI
(MedPage Today) -- CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI tr
Read MoreSTRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease
(MedPage Today) -- CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its positions in peripheral artery disease (PAD) and
Read MoreSTAT+: Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally
Will Peter Marks' ouster from the FDA change how pharma industry engages with the Trump administration?
Read MoreLong-Term Stroke Risk After TIA; Cell Signatures in Polycystic Ovary Syndrome
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech.
Read MoreRFK Jr says they are poisoning us, influencers call them unnatural – but what is the truth about seed oils?
The common cooking ingredient has sparked fierce debate since the US health secretary urged people to avoid itIt’s curious that something so bland could cause so much controversy.
Read MoreMathematician Adam Kucharski: ‘Our concepts of what we can prove are shifting’
The epidemiologist who advised on Ebola and Covid discusses the value of evidence in light of AI and social media, and how the notion of fact has long been divisiveAdam Kucharski is a professor at the
Read MoreEvery Hospital Should Offer Addiction Treatment
(MedPage Today) -- Two people are wheeled into a hospital at the same time: one for a heart attack and one for an opioid overdose.
Read MoreLower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer
(MedPage Today) -- CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher do
Read More